Editorial for "Multi-Phase MRI-Based Radiomics for Predicting Histological Grade of Hepatocellular Carcinoma"

Arthur P Wunderlich^{1

2}, Catharina Lisson^{1

2}, Michael Götz^{1

2}

Affiliations

¹ Department of Diagnostic and Interventional Radiology, Ulm University Medical Center, Ulm, Germany.
² Division for Experimental Radiology, Ulm University Medical Center, Ulm, Germany.

Editorial

Arthur P Wunderlich et al. J Magn Reson Imaging. 2024 Nov.

. 2024 Nov;60(5):2128-2129.

doi: 10.1002/jmri.29323. Epub 2024 Feb 27.

Arthur P Wunderlich^{1

2}, Catharina Lisson^{1

2}, Michael Götz^{1

2}

¹ Department of Diagnostic and Interventional Radiology, Ulm University Medical Center, Ulm, Germany.
² Division for Experimental Radiology, Ulm University Medical Center, Ulm, Germany.

No abstract available

References

1. Yokoo T, Masaki N, Parikh ND, et al. Multicenter validation of abbreviated MRI for detecting early‐stage hepatocellular carcinoma. Radiology 2023;307(2):e220917.
1. Kudo M, Izumi N, Sakamoto M, et al. Survival analysis over 28 years of 173,378 patients with hepatocellular carcinoma in Japan. Liver Cancer 2016;5(3):190‐197.
1. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42(5):1208‐1236.
1. Han Z, Dai H, Chen X, et al. Delta‐radiomics models based on multi‐phase contrast‐enhanced magnetic resonance imaging can preoperatively predict glypican‐3‐positive hepatocellular carcinoma. Front Physiol 2023;14:1138239.
1. Alksas A, Shehata M, Saleh GA, et al. A novel computer‐aided diagnostic system for accurate detection and grading of liver tumors. Sci Rep 2021;11(1):13148.